FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients

 FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients
  1. FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients  FDA.gov
  2. FDA approves first drug to treat MS in children  Healio
  3. Fingolimod OK'd for Pediatric MS  MedPage TodayFull coverage

Read More ...
FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients published May 12, 2018 at 03:35AM. Original Source Link : https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm607501.htm
loading...

Related Posts :

0 Response to "FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients"

Posting Komentar